Masazumi Takahashi Selected Research

Postgastrectomy Syndromes

1/2022	Optimal Procedures for Double Tract Reconstruction After Proximal Gastrectomy Assessed by Postgastrectomy Syndrome Assessment Scale-45.
11/2021	Defecation disorders are crucial sequelae that impairs the quality of life of patients after conventional gastrectomy.
12/2018	Background factors influencing postgastrectomy syndromes after various types of gastrectomy.
3/2017	Quality of life after total vs distal gastrectomy with Roux-en-Y reconstruction: Use of the Postgastrectomy Syndrome Assessment Scale-45.
1/2016	Assessment of postoperative quality of life following pylorus-preserving gastrectomy and Billroth-I distal gastrectomy in gastric cancer patients: results of the nationwide postgastrectomy syndrome assessment study.
10/2015	Optimal Roux-en-Y reconstruction after distal gastrectomy for early gastric cancer as assessed using the newly developed PGSAS-45 scale.
4/2015	Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS-45): a nationwide multi-institutional study.
1/2015	Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masazumi Takahashi Research Topics

Disease

36	Stomach Neoplasms (Stomach Cancer) 09/2022 - 05/2002
16	Neoplasms (Cancer) 01/2022 - 05/2002
8	Postgastrectomy Syndromes 01/2022 - 01/2015
4	Neoplasm Metastasis (Metastasis) 09/2022 - 05/2002
4	Neutropenia 01/2019 - 07/2008
3	Lymphatic Metastasis 09/2022 - 03/2006
3	Carcinoma (Carcinomatosis) 05/2006 - 01/2006
2	Adenocarcinoma 01/2022 - 07/2010
2	Colorectal Neoplasms (Colorectal Cancer) 07/2019 - 07/2009
1	Infections 09/2022
1	Margins of Excision 05/2022
1	Constipation 11/2021
1	Leukopenia 01/2019
1	Fatigue 01/2018
1	Anorexia 01/2018
1	Anemia 01/2018
1	Diarrhea 01/2018
1	Disease Progression 11/2017
1	Body Weight (Weight, Body) 07/2017
1	Weight Loss (Weight Reduction) 10/2016
1	Dumping Syndrome (Syndrome, Dumping) 01/2016
1	Gastroparesis 04/2015
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2014
1	Inflammation (Inflammations) 01/2012
1	Lymphangitis 04/2011
1	Appendicitis 01/2011
1	Leukocytosis (Pleocytosis) 01/2011
1	Colonic Neoplasms (Colon Cancer) 07/2009
1	Lung Injury 05/2008
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2008
1	Peritoneal Neoplasms 05/2006

Drug/Important Bio-Agent (IBA)

8	Docetaxel (Taxotere)FDA Link 01/2019 - 07/2008
6	S 1 (combination)IBA 02/2013 - 07/2008
4	Cisplatin (Platino)FDA LinkGeneric 10/2018 - 11/2017
3	Capecitabine (Xeloda)FDA Link 01/2018 - 11/2017
3	S-1 plus cisplatinIBA 01/2018 - 07/2012
2	NivolumabIBA 01/2022 - 01/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 07/2019
2	AlbuminsIBA 12/2018 - 01/2012
2	Biological ProductsIBA 08/2014 - 01/2006
2	C-Reactive ProteinIBA 01/2012 - 01/2011
2	Tumor Biomarkers (Tumor Markers)IBA 07/2010 - 07/2009
1	Angiogenesis InhibitorsIBA 01/2022
1	RamucirumabIBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	130-nm albumin-bound paclitaxelIBA 12/2018
1	CreatinineIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 11/2017
1	human ERBB2 proteinIBA 11/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2014
1	TegafurIBA 07/2014
1	UracilIBA 07/2014
1	NucleotidesIBA 04/2011
1	Messenger RNA (mRNA)IBA 07/2009
1	Salivary CystatinsIBA 07/2009
1	Cysteine Proteinase InhibitorsIBA 07/2009
1	Secretory Proteinase Inhibitory ProteinsIBA 05/2008
1	sivelestatIBA 05/2008

Therapy/Procedure

23	Gastrectomy 09/2022 - 05/2002
13	Drug Therapy (Chemotherapy) 01/2022 - 05/2002
9	Therapeutics 01/2021 - 07/2008
5	Adjuvant Chemotherapy 01/2019 - 05/2006
4	Lymph Node Excision (Lymph Node Dissection) 05/2006 - 09/2003
2	Gastroenterostomy 01/2016 - 01/2016
1	Length of Stay 09/2022
1	Splenectomy 09/2022
1	Operative Time 09/2022
1	Radiotherapy 01/2022
1	Immunotherapy 01/2022
1	Colectomy 01/2021
1	Neoadjuvant Therapy 10/2018
1	Combination Drug Therapy (Combination Chemotherapy) 07/2012
1	Mechanical Ventilators (Ventilator) 05/2008
1	Palliative Care (Palliative Therapy) 05/2006